The hypothesis that cellular protein carboxylmethylation reactions recognize altered aspartyl residues as part of a protein repair pathway has been tested in an in vitro system using tetragastrin (Trp-Met-Asp-Phe-NH2) as a model sequence. The L-isoaspartyl form of tetragastrin, where the phenylalanine residue is linked to the side-chain carboxyl group of the aspartate residue tetragastrin (80%). This sequence of enzymatic and nonenzymatic reactions can be coupled in a single reaction mixture; the [iso-Asp3]tetragastrin that is produced upon succinimide hydrolysis can reenter the reaction sequence by enzymatic methylation, and the net result of the process is the conversion of the isomerized peptide to the normal peptide. The efficiency of this "repair" reaction is limited by a side reaction of racemization at the a-carbon of the succinimide (half-time = 580 min). In a 24-hr time period, normal L-aspartyl-containing tetragastrin is obtained in about 50% yield from the coupled reaction mixture; other products include [D-iso-Asp3]tetragastrin and tetragastrin. The versatile chemistry of succinimide peptides suggests that methylated L-isoaspartyl sites (and possibly methylated D-aspartyl sites) in cellular polypeptides can eventually yield "repaired" normal L-aspartyl sites through succinimide intermediates.
. This sequence of enzymatic and nonenzymatic reactions can be coupled in a single reaction mixture; the [iso-Asp3]tetragastrin that is produced upon succinimide hydrolysis can reenter the reaction sequence by enzymatic methylation, and the net result of the process is the conversion of the isomerized peptide to the normal peptide. The efficiency of this "repair" reaction is limited by a side reaction of racemization at the a-carbon of the succinimide (half-time = 580 min). In a 24-hr time period, normal L-aspartyl-containing tetragastrin is obtained in about 50% yield from the coupled reaction mixture; other products include [D-iso-Asp3]tetragastrin and [D-Asp3]tetragastrin. The versatile chemistry of succinimide peptides suggests that methylated L-isoaspartyl sites (and possibly methylated D-aspartyl sites) in cellular polypeptides can eventually yield "repaired" normal L-aspartyl sites through succinimide intermediates.
Of the many enzymatic methylation reactions that have been described (1) , mammalian protein carboxyl-methylation reactions appear to be among the most flexible with regard to substrate specificity. For instance, over 40 distinct membrane and cytosolic polypeptides have been found to be methyl-acceptor substrates in intact human erythrocytes (2) (3) (4) (5) . The broad specificity of these reactions can be explained by studies showing that the common feature of methyl-acceptor sites is the occurrence of an altered aspartyl residue. For example, methylated D-aspartyl residues have been isolated from proteolytically digested erythrocyte proteins (3, 6) . The enzymatic methylation of substrates by the brain enzyme is induced by the formation of f3-isomerized L-aspartyl (isoaspartyl) sites (7) , and synthetic peptides containing L-isoaspartyl (but not normal L-aspartyl) residues are stoichiometrically methylated by both the brain and erythrocyte methyltransferases (8, 9 1 ). Succinimide formation can promote further bond rearrangements, including racemization and isomerization (6, (14) (15) (16) . Thus, it has been proposed that the function of protein carboxyl methylation is to chemically activate atypical aspartyl residues by ester formation (6) (7) (8) . Such activation will allow succinimide formation and possibly allow a partial "repair" reaction that would result in the formation of L-aspartyl residues from D-aspartyl or L-isoaspartyl residues. Such a physiological repair function might restore function to damaged proteins.
To test this hypothesis, the L-isoaspartyl form of tetragastrin ([iso-Asp3]tetragastrin; normal tetragastrin = Trp-MetAsp-Phe-NH2) was chosen as a model peptide. With purified carboxyl methyltransferase from bovine erythrocytes, the conversion of this peptide to normal tetragastrin has been achieved at the predicted efficiency. The main limitation on complete conversion appears to be the racemization of the succinimide residue. While this work was in progress, similar results were obtained with a methyltransferase from bovine brain (17 8 .0. The DEAEcellulose step separates the activity into two isozymes; the more acidic isozyme (II) was used in these experiments (J. Gilbert, I. M. Ota, and S.C., unpublished data). The purity of this enzyme preparation was estimated at 90% from gel electrophoresis in sodium dodecyl sulfate.
S-Adenosyl-L-methionine (AdoMet) hydrogen sulfate was obtained from Boehringer Mannheim, stock solutions were prepared in 10 mM HCl, and their concentration and purity were monitored by HPLC (254-nm detection). These preparations contained <1% S-adenosyl-L-homocysteine (AdoHcy). AdoHcy hydrolase was provided by B. Matuszewska and R. Borchardt products. In this scheme, the only peptide recognized by the carboxyl methyltransferase is [iso-Asp']tetragastrin. This is the only peptide that can reenter the reaction sequence, and the products that build up are normal tetragastrin and its D-aspartyl and D-isoaspartyl derivatives. Rate constants for the individual steps were determined from the data described below. The Vmx for the methyltransferase was calculated for the particular amount of enzyme used in these experiments.
as analyzed by reversed-phase HPLC. At zero reaction time, the [iso-Asp3]tetragastrin was eluted at its characteristic position in the chromatogram. At an early reaction time (28 min), the formation of the methylated product ([isoAsp(OMe)3]tetragastrin) was seen as well as [Asu3]tetragastrin. As will be shown below, the succinimide derivative was the immediate product of [iso-Asp(OMe)3]tetragastrin demethylation. Fig. 2 also shows a later time point (24 hr) in the reaction sequence. Three new peaks not observed at earlier times were present as major components. These new species were determined to be [D-iso-Asp3Itetragastrin, [D-Asp3]tetragastrin, and normal L-aspartyl-containing tetragastrin. Thus, at some stage of the reaction, epimerization and isomerization at the aspartyl center had occurred. The major product of this reaction is the normal peptide, which represents a net "repair" of L-isoaspartyl-containing tetragastrin to the normal form under these conditions.
With the intent of driving the reaction to completion, more methyltransferase and AdoMet were added to the reaction after 24 hr, and the incubation was continued for an additional 17.5 hr. The uppermost chromatogram in Fig. 2 (Fig. 2) . We hypothesize that the combination of enzymatic and nonenzymatic steps shown schematically in Fig. 3 results in a net "repair" reaction with a significant build-up of epimerized by-products. We next examined the intermediate stages of this overall process.
The First
Step of the "Repair" Reaction: Enzymatic Methylation of the Isoaspartyl Peptide. The enzymatic methylation of [iso-Asp3]tetragastrin is described by simple MichaelisMenten kinetics. The Km for the bovine erythrocyte enzyme of this peptide was determined here to be 3 ± 1 x 10-6 M at pH 7.4 using assay conditions similar to those described in Fig. 2 (data not shown) . This Km value is similar to the value of 5 x 10-6 M measured for the human erythrocyte methyltransferase and is comparable to values for other Lisoaspartyl-containing peptides (9 (Fig.  4) . As the ring-opening proceeded, the four expected prod- gastrin to tetragastrin is equal to that of the reverse reaction.
Isoaspartyl "Repair" by Coupled Enzymatic/Nonenzymatic Steps. Reaction mixtures containing [iso-Asp3]tetragastrin, carboxyl methyltransferase, and AdoMet were analyzed over a time course exceeding 24 hr (Fig. 5) . The amount of methyltransferase activity present was sufficient to convert [iso-Asp3]tetragastrin to [iso-Asp(OMe)3]tetragastrin at a velocity of 0.4 ,uM per min. Experiments were performed with and without an enzymatic scavenging system (AdoHcy hydrolase and adenosine deaminase) to deplete AdoHcy and to relieve the end-product inhibition of the methylation reaction by this species. Fig. 5 shows that the behavior of the coupled reaction system could be described on the basis of the behavior of the individual steps of the reaction studied above. [iso-Asp3]Tetragastrin was quickly consumed, and the methylated product was gradually converted to the succinimide derivative. As the reaction proceeded, the nonmethylatable products (normal, , and [D-iso-Asp3]tetragastrins) continued to build up. When the experimental data were compared to theoretical predictions based on the kinetic constants determined above (Km, Vmax, ki, k2, k3, k4, k5; see Fig. 3 noted that the experimental recovery of normal tetragastrin was somewhat below the theoretical efficiency ofthis process in both cases. At 1600 min of reaction time, approximately 60% of the total peptide was predicted to be in the normal configuration, while (by extrapolation) the experimental yield would not quite be 50%. This lowered yield of "repaired" normal product could be due to methyltransferase denaturation or a selective degradation of a small amount of normal peptide by a contaminating protease. It seems clear, however, that the experimental behavior of the system is very close to the predicted model.
DISCUSSION
The substoichiometry of mammalian protein carboxyl-methylation reactions has made it difficult to follow the chemical events following the spontaneous loss of the methyl ester (11) . The availability of peptide substrates for this enzyme (7) (8) (9) has recently made possible the observation that demethylation can occur via an intramolecular reaction leading to succinimide formation (12, 13) . In the experiments described here, we have used tetragastrin peptides to follow the further spontaneous epimerization and hydrolysis of the succinimide derivative, and the entire sequence of enzymatic and nonenzymatic reactions (Fig. 3) has been coupled in a single mixture (Fig. 5) .
The formation of normal tetragastrin from [iso-Asp3]-tetragastrin suggests that an L-isoaspartyl residue in a protein could potentially be converted to a normal L-aspartyl residue. These experiments have been performed under physiological conditions of pH and temperature and with concentrations of protein carboxyl methyltransferase similar to those found in intact erythrocytes. In these cells, which lack the capacity for protein synthesis, the accumulation of potentially nonfunctional isoaspartyl proteins may limit their life span in the circulation. The presence ofthe methylation system may help to insure that erythrocytes continue to function for their 120-day existence.
It should be stressed that the sequences of reactions observed in this study with purified methyltransferase and peptide substrates may not describe the net effect of the methylation reaction in proteins. Although L-isoaspartylcontaining peptides are now firmly established as stoichiometric substrates for mammalian protein carboxyl' methyltransferase (7) (8) (9) 19) , no (5, 20) or by the misincorporation of L-aspartyl residues in protein synthesis (8) . If (pH 7.4) . The amounts of each derivative were quantified from the UV absorbance of the HPLC peaks. Under the second set of conditions, giving closed-symbol data, AdoHcy hydrolase and adenosine deaminase were included in the incubation mixture to remove the product inhibitor AdoHcy [30 Ml of 1.7 mM AdoMet, methylation of infrequent D-aspartyl sites occurs in vivo. However, no model peptides containing D-aspartyl residues have been found to act as in vitro substrates for the erythrocyte or brain methyltransferases (8, 9) . Such methylated residues would be expected to demethylate spontaneously to the D-succinimide residue, which could then epimerize to the L-succinimide residue and yield normal and L-isoaspartyl sites as products. Thus, rapid epimerization of succinimides may enable D-aspartyl damage to be at least partly repaired. This pathway could not be very efficient, however, since D-succinimide hydrolysis would be expected to yield substantial amounts of the D-isoaspartyl derivative, and no evidence has been presented for the methylation of such a product. 
